Kovalenko SA - Search Results

1

Mitochondrial DNA mutations in cardiomyopathy: combination of replacements yielding cysteine residues and tRNA mutations.

Tanaka M, Obayashi T, Yoneda M, Kovalenko SA, Sugiyama S, Ozawa T. Tanaka M, et al. Among authors: kovalenko sa. Muscle Nerve Suppl. 1995;3:S165-9. doi: 10.1002/mus.880181432. Muscle Nerve Suppl. 1995. PMID: 7603519

2

A common hot spot for somatic and germline mutations in rat mitochondrial DNA: analysis by fluorescence-based SSCP.

Kovalenko SA, Tanaka M, Borgeld HJ, Ozawa T. Kovalenko SA, et al. Biochem Mol Biol Int. 1994 Dec;34(6):1205-14. Biochem Mol Biol Int. 1994. PMID: 7696993

3

Accumulation of somatic nucleotide substitutions in mitochondrial DNA associated with the 3243 A-to-G tRNA(leu)(UUR) mutation in encephalomyopathy and cardiomyopathy.

Kovalenko SA, Tanaka M, Yoneda M, Iakovlev AF, Ozawa T. Kovalenko SA, et al. Biochem Biophys Res Commun. 1996 May 15;222(2):201-7. doi: 10.1006/bbrc.1996.0722. Biochem Biophys Res Commun. 1996. PMID: 8670183

4

Simple methods for preparation of plasmid DNA yielding long and accurate sequence data.

Kovalenko SA, Tanaka M, Ozawa T. Kovalenko SA, et al. Nucleic Acids Res. 1994 Dec 25;22(25):5771-2. doi: 10.1093/nar/22.25.5771. Nucleic Acids Res. 1994. PMID: 7838738 Free PMC article.

5

Accumulation of deletions and point mutations in mitochondrial genome in degenerative diseases.

Tanaka M, Kovalenko SA, Gong JS, Borgeld HJ, Katsumata K, Hayakawa M, Yoneda M, Ozawa T. Tanaka M, et al. Among authors: kovalenko sa. Ann N Y Acad Sci. 1996 Jun 15;786:102-11. doi: 10.1111/j.1749-6632.1996.tb39055.x. Ann N Y Acad Sci. 1996. PMID: 8687011

6

Method for in situ investigation of mitochondrial DNA deletions.

Kovalenko SA, Harms PJ, Tanaka M, Baumer A, Kelso J, Ozawa T, Linnane AW. Kovalenko SA, et al. Hum Mutat. 1997;10(6):489-95. doi: 10.1002/(SICI)1098-1004(1997)10:6<489::AID-HUMU12>3.0.CO;2-W. Hum Mutat. 1997. PMID: 9401014

7

An age-associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle.

Kopsidas G, Kovalenko SA, Kelso JM, Linnane AW. Kopsidas G, et al. Among authors: kovalenko sa. Mutat Res. 1998 Oct 12;421(1):27-36. doi: 10.1016/s0027-5107(98)00150-x. Mutat Res. 1998. PMID: 9748486

8

Preferential amplification is minimised in long-PCR systems.

Kopsidas G, Kovalenko SA, Islam MM, Gingold EB, Linnane AW. Kopsidas G, et al. Among authors: kovalenko sa. Mutat Res. 2000 Nov 30;456(1-2):83-8. doi: 10.1016/s0027-5107(00)00126-3. Mutat Res. 2000. PMID: 11087899

9

Yarovaya NO, Kramarova L, Borg J, Kovalenko SA, Caragounis A, Linnane AW. Yarovaya NO, et al. Among authors: kovalenko sa. Biogerontology. 2002;3(1-2):25-7. doi: 10.1023/a:1015295011131. Biogerontology. 2002. PMID: 12014836 Review.

10

Stochastic mitochondrial DNA changes: bioenergy decline in type I skeletal muscle fibres correlates with a decline in the amount of amplifiable full-length mtDNA.

Kopsidas G, Zhang C, Yarovaya N, Kovalenko S, Graves S, Richardson M, Linnane AW. Kopsidas G, et al. Biogerontology. 2002;3(1-2):29-36. doi: 10.1023/a:1015290810222. Biogerontology. 2002. PMID: 12014837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page